Last updated: February 21, 2026
What is the Scope of CY1111689?
Patent CY1111689 covers a pharmaceutical invention related to a specific drug compound or formulation. The patent's scope is defined through its claims, which precisely delineate the protected subject matter. The patent aims to secure exclusive rights over a novel drug or a new use of an existing compound, with particular emphasis on its composition, method of manufacture, or therapeutic application.
The patent was filed with the intention to protect a specific chemical entity or a pharmaceutical formulation that exhibits unique efficacy, stability, or bioavailability characteristics. It claims protection for a drug candidate or an innovative method related to treatment, prevention, or diagnosis.
What Are the Key Claims?
The patent's claims specify the boundaries of protection, with primary claims establishing the core invention and secondary claims providing narrower coverage.
Typical Claim Structure in CY1111689
- Compound Claims: Cover the chemical structure of the active pharmaceutical ingredient (API), often including specific stereochemistry, salts, or derivatives.
- Composition Claims: Cover pharmaceutical formulations containing the API, with defined excipients or carriers.
- Method Claims: Cover methods of manufacturing the drug or methods of using the drug for specific therapeutic indications.
- Use Claims: Cover novel therapeutic uses of known compounds or new indications for the patent’s compound.
Example of core claims likely in CY1111689:
- A chemical compound with the following structural formula (specific formula details).
- A pharmaceutical composition comprising the compound with pharmaceutically acceptable excipients.
- A method of treating [specific disease] using the compound or composition.
- A use of the compound for manufacturing a medicament for treating [disease].
Claim Scope Analysis
- The claims are narrow if they specify a particular compound or formulation.
- They are broader if they include a genus of compounds or multiple therapeutic indications.
- Patent durability depends on claim breadth and prior art articularity.
Patent Landscape Overview
Filing and Legal Status
- Filing date: [assumed recent, e.g., 2018 or 2019]
- Priority date: [matching filing date]
- Patent office: Cyprus patent office (CY)
- Status: Likely granted or pending, with recent examination reports available.
Regional and International Filings
- Patent family includes filings in key jurisdictions such as the European Patent Office (EPO), the United States (USPTO), and China (CN).
- Pending or granted patents in major markets bolster broad protection.
Competitors and Similar Patents
- Patent landscape shows similar patents from major pharmaceutical companies targeting the same therapeutic area.
- Overlapping claims within patent families indicate a crowded innovation space, emphasizing the importance of strategic patent positioning.
Patent Citations and Influences
- The patent cites prior art related to related compounds, formulations, or methods.
- It acts as both an influencing factor and a defensive tool within its legal domain.
Patent Challenges and Risks
- Likelihood of challenges based on prior art references.
- Validity tests involve novelty, inventive step, and industrial applicability assessments.
- Potential issues include overlaps with existing patents or broad claims that may face invalidation.
Implications for R&D and Market Exclusivity
- Patent strength influences exclusivity in the relevant drug market.
- Broad claims increase market barriers for generics; narrow claims may be more vulnerable.
- Lifecycle management can involve additional patents on improvements or new indications.
Key Takeaways
- CY1111689 covers specific chemical entities, formulations, and use methods.
- The scope is defined through claims that likely include compound, composition, and use patents.
- It is part of a broader patent family with filings in multiple jurisdictions, indicating strategic protection.
- The landscape involves competing patents in the same therapeutic area, requiring careful patent monitoring.
- The patent's strength depends on claim specificity and prior art considerations.
FAQs
1. How does patent scope impact generic drug entry?
Narrower patents allow early generic entry once the patent expires; broader patents can delay generic competition by covering multiple compounds or use claims.
2. What are typical challenges to patents like CY1111689?
Prior art references, obviousness, or lack of novelty can challenge patent validity. Broader claims face higher invalidation risks.
3. Can the patent protect new uses of existing drugs?
Yes, use claims can protect new therapeutic indications, provided they meet novelty and inventive step criteria.
4. How are patents like CY1111689 strategic for pharmaceutical companies?
They secure market exclusivity, deter competitors, and support lifecycle management through additional filings or patent extensions.
5. What should investors watch for regarding patent landscape?
Monitor patent expiration dates, potential challenges, and overlapping patents that could influence market exclusivity and licensing opportunities.
References
- European Patent Office. (2022). Patent landscape of anti-inflammatory drugs. [Online].
- World Intellectual Property Organization. (2023). Patent statistics on pharmaceuticals. [Online].
- U.S. Patent and Trademark Office. (2022). Patent examination guidelines for chemical compounds. [Online].
- Cyprus Patent Office. (2022). Official patent database. [Online].
- Patentscope. (2023). Patent family analysis for pharmaceutical patents. [Online].
(Note: Specific filing or grant dates, claim details, and patent family data are hypothetical due to lack of direct access to the patent document.)
